UTILIZATION OF MEASLES CONJUGATED VACCINE 2 AND ASSOCIATED FACTORS AMONG CHILDREN AGED 24-35 MONTHS IN NORTH MECHA DISTRICT, WEST GOJJAM ZONE, NORTH WEST ETHIOPIA

ASICHALEW, ABIYU

dc.contributor.author	ASICHALEW, ABIYU
dc.date.accessioned	2022-03-29T05:26:52Z
dc.date.available	2022-03-29T05:26:52Z
dc.date.issued	2022-03-27
dc.identifier.uri	http://ir.bdu.edu.et/handle/123456789/13366
dc.description.abstract	Background: -Measles is a highly infectious disease caused by a virus. It remains an important cause of death among young children globally, despite the availability of a safe and effective vaccine. More than 95% of measles deaths occur in countries with low incomes and weak health infrastructures. According to mini EDHS 2019 Fifty nine percent of 12-23 months children received measles conjugated vaccine 1 and 9% of children age 24-35 months received the second dose of the measles vaccine.	en_US
dc.language.iso	en	en_US
dc.subject	- Measles conjugated vaccine 2, 24-35 month age children, associated factors, and North Mecha district.	en_US
dc.title	UTILIZATION OF MEASLES CONJUGATED VACCINE 2 AND ASSOCIATED FACTORS AMONG CHILDREN AGED 24-35 MONTHS IN NORTH MECHA DISTRICT, WEST GOJJAM ZONE, NORTH WEST ETHIOPIA	en_US
dc.type	Thesis	en_US